Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4'-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis

• मुख्य लेखकों: Erica Franceschinis (लेखक), Marco Roverso (लेखक), Daniela Gabbia (लेखक), Sara De Martin (लेखक), Matteo Brusegan (लेखक), Christian Vaccarin (लेखक), Sara Bogialli (लेखक), Adriana Chilin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2022-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

4,6,4'-trimethylangelicin (TMA) is a promising pharmacological option for the treatment of cystic fibrosis (CF) due to its triple-acting behavior toward the function of the CF transmembrane conductance regulator. It is a poorly water-soluble drug, and thus it is a candidate for developing a sel...